Novo Nordisk stock steadies as lower-dose Wegovy pill trial advances
Novo Nordisk (ISIN DK0060534915) stock is trading in a tight range in late August 2026, with the company…
Novo Nordisk stock holds firm after guidance hike and buybacks
Novo Nordisk stock (ISIN DK0060534915) is holding steady as of August 21, 2026, with the New York-listed shares…
Novo Nordisk stock steadies as new Wegovy pill study follows strong Q2 2026
Novo Nordisk A/S (ISIN DK0060534915) stock is holding its ground in August 2026 as investors weigh solid second…
Novo Nordisk stock benefits as France moves to reimburse Wegovy and new obesity trial begins
Novo Nordisk stock, tied to ISIN DK0060534915, is navigating a pivotal phase for its obesity franchise as of…
Novo Nordisk stock slides as Lilly pressure and 5 million Wegovy pill prescriptions draw attention
Novo Nordisk stock is under pressure as Eli Lilly competition and the Wegovy pill’s 5 million-plus U.S. prescriptions…
Novo Nordisk stock holds near highs as obesity and diabetes growth underpins earnings
Novo Nordisk stock (ISIN DK0060534915) is trading close to its recent highs as the Danish pharmaceutical group benefits…
Novo Nordisk stock gains on diabetes and obesity demand
Novo Nordisk (ISIN DK0060534915) remains one of the most closely watched large-cap healthcare names in Europe, with its…
Novo Nordisk stock trades near record levels as Wegovy momentum supports earnings outlook
Novo Nordisk stock is trading close to its recent record levels as the Danish pharmaceutical group (ISIN DK0060534915)…
Novo Nordisk stock holds near record territory as Wegovy and Ozempic drive double digit growth
Novo Nordisk stock, tied to ISIN DK0060534915, remains supported by robust fundamentals as the Danish pharmaceutical group benefits…
Wegovy by Novo Nordisk – once-weekly pen reshapes obesity care
Wegovy by Novo Nordisk lands on the kitchen table as a slim, mint?green injection pen next to the…
Novo Nordisk stock reflects a steady diabetes and obesity franchise
Novo Nordisk stock represents exposure to one of the most established diabetes and obesity treatment franchises worldwide. The…
Novo Nordisk stock holds focus on obesity medicine demand
Novo Nordisk, DK0060534915
Veröffentlicht: 09.07.2026 um 13:50 Uhr,
Redaktion AD HOC NEWS,…